FM19G11 and Ependymal Progenitor/Stem Cell Combinatory Treatment Enhances Neuronal Preservation and Oligodendrogenesis after Severe Spinal Cord Injury

@inproceedings{AlastrueAgudo2018FM19G11AE,
  title={FM19G11 and Ependymal Progenitor/Stem Cell Combinatory Treatment Enhances Neuronal Preservation and Oligodendrogenesis after Severe Spinal Cord Injury},
  author={Ana Alastrue-Agudo and Francisco Javier Rodr{\'i}guez-Jim{\'e}nez and Eric L{\'o}pez Mocholi and Francesca De Giorgio and Slaven Erceg and Victoria Moreno-Manzano},
  booktitle={International journal of molecular sciences},
  year={2018}
}
Spinal cord injury (SCI) suffers from a lack of effective therapeutic strategies. We have previously shown that individual therapeutic strategies, transplantation of ependymal stem/progenitor cells of the spinal cord after injury (epSPCi) or FM19G11 pharmacological treatment, induce moderate functional recovery after SCI. Here, the combination of treatments… CONTINUE READING